Rigmor Thorstensson

Solna, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.

Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.

Journal: The Lancet. Infectious diseases

Published: January 08, 2020

Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.

Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans.

Journal: The Journal of clinical investigation

Published: November 14, 2019

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.

Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy.

Journal: Infectious diseases (London, England)

Published: September 29, 2015

Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine.

Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine.

Journal: Clinical and vaccine immunology : CVI

Published: July 11, 2014

B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.

B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.

Journal: Vaccine

Published: February 05, 2014

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.

A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.

Journal: PloS one

Published: February 03, 2013

Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.

Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.

Journal: Vaccine

Published: December 19, 2012

Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses.

Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses.

Journal: Journal of immunological methods

Published: December 07, 2012

Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.

Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.

Journal: PloS one

Published: August 16, 2012

The Swedish child vaccination program also reaches the children born abroad. Serologic samples show good protection compared to Swedish-born

The Swedish child vaccination program also reaches the children born abroad. Serologic samples show good protection compared to Swedish-born

Journal: Lakartidningen

Published: March 28, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026